Literature DB >> 8926115

Development of a germfree mouse model of Vibrio cholerae infection.

J R Butterton1, E T Ryan, R A Shahin, S B Calderwood.   

Abstract

A mouse model of Vibrio cholerae infection was successfully developed with germfree mice. Three- to four-week-old germfree mice were orally inoculated with strains of V. cholerae to be tested and then moved to normal housing after inoculation. Stool culture, measurement of serum vibriocidal antibody titers, and determination of immune responses to the cholera toxin B subunit demonstrated that germfree mice are readily colonized by V cholerae and develop systemic and mucosal immune responses to antigens expressed by these organisms. Immune responses to the B subunit of Shiga toxin 1, which was expressed from a V. cholerae vaccine vector, were less pronounced. This model should be valuable for studying immune responses to V. cholerae infection and immunization, including responses to heterologous antigens expressed by cholera vector strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926115      PMCID: PMC174383          DOI: 10.1128/iai.64.10.4373-4377.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

2.  M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration.

Authors:  R L Owen; N F Pierce; R T Apple; W C Cray
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

3.  Immune response in germfree mice orally immunized with Vibrio cholerae.

Authors:  T Shimamura
Journal:  Keio J Med       Date:  1972-06

4.  Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae.

Authors:  R B Sack; C E Miller
Journal:  J Bacteriol       Date:  1969-09       Impact factor: 3.490

5.  Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies.

Authors:  R Freter; P C O'Brien; M S Macsai
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.

Authors:  W C Cray; E Tokunaga; N F Pierce
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Modifications of the local immune response to Vibrio cholerate attributed to the intestinal microbial flora of the mouse.

Authors:  D J Horsfall; D Rowley
Journal:  Aust J Exp Biol Med Sci       Date:  1978-10

8.  Immunological conversion of Vibrio chorlerae in gnotobiotic mice.

Authors:  C E Miller; K H Wong; J C Feeley; M E Forlines
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

9.  Heterologous antigen expression in Vibrio cholerae vector strains.

Authors:  J R Butterton; D T Beattie; C L Gardel; P A Carroll; T Hyman; K P Killeen; J J Mekalanos; S B Calderwood
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 10.  The role of the liver in translocation of IgA into the gastrointestinal tract.

Authors:  W R Brown; T M Kloppel
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

View more
  29 in total

1.  Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains.

Authors:  T I Crean; M John; S B Calderwood; E T Ryan
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains.

Authors:  Verena Olivier; G Kenneth Haines; Yanping Tan; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

3.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

Review 4.  Role of mucosal dendritic cells in inflammatory bowel disease.

Authors:  Jan Hendrik Niess
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 5.  Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.

Authors:  Klara Kubelkova; Milota Benuchova; Hana Kozakova; Marek Sinkora; Zuzana Krocova; Jaroslav Pejchal; Ales Macela
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

6.  Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse.

Authors:  Ashfaqul Alam; Regina C Larocque; Jason B Harris; Cecily Vanderspurt; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.

Authors:  E T Ryan; J R Butterton; T Zhang; M A Baker; S L Stanley; S B Calderwood
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

8.  Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.

Authors:  Brandon Sit; Bolutife Fakoya; Ting Zhang; Gabriel Billings; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

9.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

10.  Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.

Authors:  Christofer J Vindurampulle; Stephen R Attridge
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.